Takahashi Yusuke, Moiseyev Gennadiy, Ma Jian-Xing
Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104; Harold Hamm Diabetes Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104.
Harold Hamm Diabetes Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104; Department of Physiology, and University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104.
J Biol Chem. 2014 Sep 26;289(39):26743-26751. doi: 10.1074/jbc.M114.558619. Epub 2014 Aug 11.
RPE65 is the retinoid isomerohydrolase that converts all-trans-retinyl ester to 11-cis-retinol, a key reaction in the retinoid visual cycle. We have previously reported that cone-dominant chicken RPE65 (cRPE65) shares 90% sequence identity with human RPE65 (hRPE65) but exhibits substantially higher isomerohydrolase activity than that of bovine RPE65 or hRPE65. In this study, we sought to identify key residues responsible for the higher enzymatic activity of cRPE65. Based on the amino acid sequence comparison of mammalian and other lower vertebrates' RPE65, including cone-dominant chicken, 8 residues of hRPE65 were separately replaced by their counterparts of cRPE65 using site-directed mutagenesis. The enzymatic activities of cRPE65, hRPE65, and its mutants were measured by in vitro isomerohydrolase activity assay, and the retinoid products were analyzed by HPLC. Among the mutants analyzed, two single point mutants, N170K and K297G, and a double mutant, N170K/K297G, of hRPE65 exhibited significantly higher catalytic activity than WT hRPE65. Further, when an amino-terminal fragment (Met(1)-Arg(33)) of the N170K/K297G double mutant of hRPE65 was replaced with the corresponding cRPE65 fragment, the isomerohydrolase activity was further increased to a level similar to that of cRPE65. This finding contributes to the understanding of the structural basis for isomerohydrolase activity. This highly efficient human isomerohydrolase mutant can be used to improve the efficacy of RPE65 gene therapy for retinal degeneration caused by RPE65 mutations.
RPE65是一种视黄醛异构水解酶,它将全反式视黄酯转化为11-顺式视黄醇,这是视黄醛视觉循环中的关键反应。我们之前报道过,以视锥细胞为主的鸡RPE65(cRPE65)与人类RPE65(hRPE65)的序列同一性为90%,但其异构水解酶活性显著高于牛RPE65或hRPE65。在本研究中,我们试图确定导致cRPE65具有更高酶活性的关键残基。基于哺乳动物和其他低等脊椎动物(包括以视锥细胞为主的鸡)RPE65的氨基酸序列比较,使用定点诱变将hRPE65的8个残基分别替换为cRPE65的对应残基。通过体外异构水解酶活性测定来测量cRPE65、hRPE65及其突变体的酶活性,并通过高效液相色谱法分析视黄醛产物。在所分析的突变体中,hRPE65的两个单点突变体N170K和K297G以及一个双突变体N170K/K297G表现出比野生型hRPE65显著更高的催化活性。此外,当hRPE65的N170K/K297G双突变体的氨基末端片段(Met(1)-Arg(33))被相应的cRPE65片段替换时,异构水解酶活性进一步提高到与cRPE65相似的水平。这一发现有助于理解异构水解酶活性的结构基础。这种高效的人类异构水解酶突变体可用于提高RPE65基因治疗由RPE65突变引起的视网膜变性的疗效。